Singular Genomics Systems, Inc. (OMIC) Reports In-Line Q4 EPS

Singular Genomics Systems, Inc. (NASDAQ: OMIC) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $829.67 thousand.

For earnings history and earnings-related data on Singular Genomics Systems, Inc. (OMIC) click here.

You May Also Be Interested In

• Imunon (IMNN) Tops Q2 EPS by 39c
• Achieve Life Sciences (ACHV) Misses Q2 EPS by 64c
• First Solar raised at Baird as Section 232 clears path for bookings